BENESKI BENJAMIN MACHINAS (SVP, Chief Technical Officer) sold 3.5% of their position (7.55K shares) of ALLOGENE THERAPEUTICS, INC. on the open market
Open‑market sale worth $13.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/4/2026ACC: 0001737287-26-000011
Officer· SVP, Chief Technical Officer
Since Mar 2026
+471.93K
Net shares
Net buyer
$13.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
479.48K acquired · 7.55K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.55K
Price / share
$1.73
Trade value
$13.06K
% of position
3.5%
2/2/2026
217.72K→210.17K
Total
Net shares
−7.55K
Net value
-$13.06K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | S · Sale | −7.55K | $1.73 | $13.06K | 3.5% | 217.72K | 210.17K |
| Total | −7.55K | -$13.06K | ||||||
Derivative Transactions2
Stock Option (Right to buy)
Direct
Converts to
Common Stock
373.76K shares
Shares
+373.76K
Strike price
1.87
Held after
373.76K
Exercisable
—
2/2/2026
Restricted Stock Unit
Direct
Converts to
Common Stock
105.72K shares
Shares
+105.72K
Strike price
Held after
105.72K
Exercisable
—
2/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy) Direct | Common Stock373.76K shares | 2/2/2026 | A · Award | +373.76K | 1.87 | — | 373.76K |
| Restricted Stock Unit Direct | Common Stock105.72K shares | 2/2/2026 | A · Award | +105.72K | — | 105.72K |